Rapid Micro Biosystems, Inc.
NASDAQ:RPIDMedical - Devices
+$0.03 today
- Market cap
- $50.31M
- Beta
- 1.46
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$1.10
Volume 0.17M
Average 0.18M
RPID Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Rapid Micro Biosystems, Inc.NASDAQ: RPID
Other Non-Cash Items · Q1 FY2026 · quarter ended Mar 2026
Other non-cash items dips below year-ago levels
Q1 FY2026 other non-cash items of $510K fell 15.0% year over year, behind the +324.3% change in trailing-twelve-month other non-cash items. Sequentially, it fell 79.2% from the prior quarter. Over 3 fiscal years it compounded at +55.0% a year.
Context
- Other non-cash items amounted to 8.1% of revenue in FY2025, up 7.1 pp from a year earlier.
- Other non-cash items increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -15.0% toward the trailing-twelve-month pace of +324.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- 2.71M USD
- Year-over-year change
- +900.7%
- 4-year CAGR
- -41.5%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.71M | +900.7% |
| FY2024 | 2024-12-31 | 271K | +126.5% |
| FY2023 | 2023-12-31 | (1.02M) | -240.7% |
| FY2022 | 2022-12-31 | 728K | -96.9% |
| FY2021 | 2021-12-31 | 23.19M | — |
Other Non-Cash Items vs competitors
How RPID compares with its peers on the latest reported figures
- RPID's LTM Mar 2026 other non-cash items of $4.13M is the 4th largest of the 9 companies compared; the peer median is $1.77M.
- Its year-over-year change of +324.3% is the 4th highest of 8, against a peer median of +118.8%.
- Other non-cash items amounts to 12.0% of revenue for RPID, versus a peer median of 38.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $23.91B | +161769.7% | +139.5% | 465745.8% | |
| LTM Mar 2026 | $33.28M | +1480.2% | — | 31.1% | |
| LTM Mar 2026 | $26.81M | -156.2% | +158.7% | 46.5% | |
| LTM Mar 2026 | $4.13M | +324.3% | +55.0% | 12.0% | |
| LTM Mar 2026 | $3.34M | +84.6% | +25.7% | 4.6% | |
| LTM Mar 2026 | $2.83M | +118.8% | +48.1% | 5.1% | |
| LTM Mar 2026 | $699K | +677.7% | +55.5% | 1226.3% | |
| LTM Mar 2026 | $404K | — | — | — | |
| LTM Mar 2026 | $125K | -60.3% | — | — | |
| Peer median (excluding RPID) | $1.77M | +118.8% | +55.5% | 38.8% | |
Competitors are the stored peer set for RPID. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (73.52M) | (60.81M) | (52.47M) | (46.89M) | (47.12M) |
| Depreciation & Amortization | 1.53M | 2.84M | 3.11M | 3.36M | 3.25M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.84M | 4.02M | 4.75M | 3.87M | 4.03M |
| Change in Working Capital | (8M) | (5.33M) | 555K | (4.77M) | 6.06M |
| Accounts Receivables | (17K) | (364K) | (163K) | (1.99M) | 4.39M |
| Inventory | (6.77M) | (5.84M) | 1.19M | (335K) | 1.47M |
| Accounts Payables | (524K) | 1.48M | (3.46M) | 562K | 1.6M |
| Other Working Capital | (691K) | (602K) | 2.98M | (3.01M) | (1.39M) |
| Other Non-Cash Items | 23.19M | 728K | (1.02M) | 271K | 2.71M |
| Operating Cash Flow | (54.96M) | (58.55M) | (45.08M) | (44.15M) | (31.06M) |
| Capital Expenditures | (3.22M) | (6.74M) | (1.85M) | (1.37M) | (850K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (25.09M) | (179.23M) | (62.49M) | (35.04M) | (27.08M) |
| Sales of Investments | 15M | 92.5M | 106.49M | 73.06M | 42.26M |
| Other Investing Activities | 20K | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (13.29M) | (93.47M) | 42.15M | 36.66M | 14.33M |
| Debt Repayment | (26.17M) | (33K) | (37K) | (35K) | 19.09M |
| Common Stock Issued | 164.11M | 0 | 0 | 238K | 1.1M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (940K) | 726K | 186K | 0 | (419K) |
| Financing Cash Flow | 216.75M | 693K | 149K | 203K | 19.77M |
| Effect of Forex Changes | 0 | 0 | 0 | (81K) | 0 |
| Net Change in Cash | 148.49M | (151.32M) | (2.78M) | (7.37M) | 3.04M |
| Free Cash Flow | (58.18M) | (65.29M) | (46.93M) | (45.52M) | (31.91M) |
Rapid Micro Biosystems, Inc.
NASDAQ:RPID
Intrinsic Alpha fair value
Locked
Current Price
$1.11
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.